# Performance and Safety of Bone Substitute MBCP-FS in Maxillary Sinus Lift Procedures

> **NCT00163605** · PHASE2,PHASE3 · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 86 (—)

## Conditions studied

- Sinus Implant Reconstruction

## Interventions

- **DEVICE:** Macroporous Biphasic Calcium Phosphate-Fibrin Sealant Vapor Heated Solvent/Detergent Treated 4 IU/ML Thrombin (MBCP-FS)

## Key facts

- **NCT ID:** NCT00163605
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 86 (—)
- **Last updated:** 2007-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163605, "Performance and Safety of Bone Substitute MBCP-FS in Maxillary Sinus Lift Procedures". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00163605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*